FBXL7 and central nervous system cancer: Overexpression of FBXL7 almost completely reversed the inhibition of glioma cell proliferation, migration, invasion, and enhanced glioma cell sensitivity to the anti-glioma drug temozolomide by miR-152-5p overexpression [17].